J Gynecol Oncol.  2024 May;35(3):e88. 10.3802/jgo.2024.35.e88.

Author's reply to: Effect of adjuvant treatment on survival in 2023 FIGO stage IIC endometrial cancer

Affiliations
  • 1Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
  • 2Department of Obstetrics and Gynecology, College of Medicine, National Taiwan University, Taipei, Taiwan
  • 3Department of Obstetrics and Gynecology, National Taiwan University Hospital Hsin-Chu Branch, Hsinchu, Taiwan

Full Text Links
  • JGO
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2025 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr